What is the appropriate dosing and administration of Loxicard (lidocaine) for a dialysis patient with recurrent ventricular tachycardia?

Lidocaine Dosing in Dialysis Patients with Recurrent VT

For dialysis patients with recurrent ventricular tachycardia, use standard lidocaine dosing without routine adjustment: 1-1.5 mg/kg IV bolus (up to 100 mg), followed by maintenance infusion of 1-2 mg/min, as hemodialysis removes negligible amounts of lidocaine and does not require supplementation. 1, 2

Initial Bolus Dosing

For hemodynamically stable monomorphic VT in dialysis patients:

• Initial dose: 1-1.5 mg/kg IV bolus (typically 50-100 mg in adults) 1
• May repeat 0.5-0.75 mg/kg every 5-10 minutes if needed
• Maximum cumulative dose: 3 mg/kg 1

For cardiac arrest with pulseless VT:

• 100 mg bolus, may repeat after 5-10 minutes 3

Maintenance Infusion

After successful cardioversion:

• Start at 1-2 mg/min (30-50 mcg/kg/min) 1
• In heart failure patients (common in dialysis population): limit to 1 mg/min maximum 4
• Avoid higher rates (2-4 mg/min) in dialysis patients due to increased toxicity risk

Critical Dialysis-Specific Considerations

Hemodialysis does NOT significantly remove lidocaine 2:

• Only 2.8-5.6% of total dose removed during 5-hour dialysis
• Dialysis clearance: 26-29 ml/min (clinically negligible)
• No dose adjustment or supplementation needed after dialysis 2

However, dialysis patients have unique pharmacokinetic alterations:

• Elevated alpha-1-acid glycoprotein (AAG) levels increase protein binding
• Paradoxically higher unbound fractions observed (0.55-0.68) 2
• Increased risk of toxicity despite "therapeutic" total levels

Monitoring Requirements

Monitor closely for toxicity (lidocaine has narrow therapeutic window):

• Target therapeutic range: 1.5-5.0 μg/L
• Early signs: paresthesia, drowsiness, slurred speech
• Severe toxicity: muscular twitching, seizures, bradycardia 3

In dialysis patients specifically:

• Consider checking lidocaine levels if infusion exceeds 24 hours
• Watch for altered consciousness even at "therapeutic" levels
• Reduce dose if any CNS symptoms appear

Alternative Considerations

While lidocaine is guideline-supported 1, amiodarone may be preferred in certain dialysis scenarios:

• Amiodarone: 150 mg over 10 minutes, then 1 mg/min × 6 hours, then 0.5 mg/min 1
• Recent evidence suggests potential superiority for in-hospital cardiac arrest 5
• However, lidocaine remains appropriate first-line for hemodynamically stable VT 1

Common Pitfalls to Avoid

1. Do NOT reduce initial bolus dose in dialysis patients—standard dosing applies
2. Do NOT give supplemental doses after hemodialysis sessions 2
3. Do NOT use maintenance rates >2 mg/min in dialysis patients (especially with heart failure)
4. Do NOT rely solely on total lidocaine levels—clinical assessment is paramount given altered protein binding 2
5. Avoid prophylactic use—only indicated for active/recurrent VT 6

Clinical Algorithm

1. Assess hemodynamic stability first
2. If unstable: synchronized cardioversion (100-360 J) takes priority 3
3. If stable with recurrent VT:
   • Give lidocaine 1-1.5 mg/kg IV bolus
   • Start maintenance at 1 mg/min (not higher in dialysis patients)
   • Monitor for toxicity continuously
   • No adjustment needed for dialysis timing
4. If refractory: consider amiodarone or catheter ablation 6